Cargando…
Evaluation of outpatient treatment for non-hospitalised patients with COVID-19: The experience of a regional centre in the UK
INTRODUCTION: Antivirals, such as molnupiravir, and SARS-CoV-2 neutralising monoclonal antibodies (nMAbs), such as sotrovimab, reduced the risk of hospitalisation and death in clinical trials of high-risk non-hospitalised patients with Covid-19. However, the real-world benefits of these drugs are un...
Autores principales: | Goodwin, Amanda T., Thompson, Jonathan S., Hall, Ian P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016683/ https://www.ncbi.nlm.nih.gov/pubmed/36920896 http://dx.doi.org/10.1371/journal.pone.0281915 |
Ejemplares similares
-
Pathways for outpatient management of venous thromboembolism in a UK centre
por: Condliffe, Robin
Publicado: (2016) -
Outpatient parenteral antimicrobial therapy for leishmaniasis: 13 years’ experience at a large UK infectious diseases centre
por: Parkash, Vivak, et al.
Publicado: (2023) -
Outpatient treatment with the wearable cardioverter defibrillator: clinical experience in two Dutch centres
por: Quast, A. F. B. E., et al.
Publicado: (2017) -
Provision of COVID-19 treatments to non-hospitalised patients in Northern Ireland: an evaluation
por: Patterson, L, et al.
Publicado: (2023) -
Laboratory Features of Hospitalised Patients with COVID-19 in Jersey, UK
por: Gama, Sergio, et al.
Publicado: (2022)